Interested in Connecting? Please contact: John Kaiser CEO firstname.lastname@example.org
Message the company or request a 1:1 meeting here.
Evecxia Therapeutics, Inc. is a private, clinical stage spin-out from Duke University, located in the Research Triangle Park, NC. Evecxia’s mission is to help people with disabling mental illness lead fuller, more meaningful lives. Evecxia is developing a new class of drugs based on 5-hydroxytryptophan (5-HTP) as the active compound. In humans, 5-HTP has shown therapeutic promise across multiple indications; but, poor pharmacokinetics makes native 5-HTP undruggable. Deploying unique know-how and proprietary technologies, Evecxia is the first company dedicated to realizing the therapeutic potential of 5-HTP via specialty Rx formulation drugs.